Proactive’s CEO Spotlight Investor Briefings Melbourne and Sydney

Managing director Dr Richard Lipscombe showcased the company and PromarkerD, the world leading predictive diagnostic test for diabetic kidney disease, at Investor Briefings as part of Proactive’s CEO Spotlight Investor Session in Melbourne (11th April) and Sydney (12th April).170407-PIQ-Corporate-presentation-Proactive-170407PIRL

Investor presentation: Global leader in applying proteomics to MedTech


  • This field is for validation purposes and should be left unchanged.